Skip to main content

Morning Bell 16 November

Jessica Amir
November 16, 2020

The ASX200 is eyeing a gain of 0.8% at the open following global equities charging higher on Friday. Last week the Aussie share market gained 3.5%, hitting an 8-month high.

What to watch today:

  • CSL (ASX:CSL) announced it’s building a new vaccine manufacturing plant near Melbourne airport in Victoria, which will be the biggest vaccine facility in the southern hemisphere. The government will sign a $1 billion agreement with CSL to supply Australia with products until 2036 and the plant will be ready in 2026.
  • Keep an eye on Hydrogen stocks like Hazer (ASX:HZR) and Woodside (ASX:WPL), given the government is pushing for hydrogen to play a major part in carbon-neutral transport, power generation and manufacturing.
  • GrainCorp (ASX:GNC) and Elders (ASX:ELD) report results today.
  • BWX (ASX:BWX) holds its AGM today.
  • U.S. housing sales, retail sales and industrial production will be released this week, Australian unemployment numbers will be released Thursday and retail sales are out on Friday.

Local trading ideas:

  • Bell Potter upgraded Lovisa’s (ASX:LOV) Buy rating, increasing its target to $13.50, implying 18% upside in a year from Friday’s close of $11.48.
  • Bell Potter upgraded media and marketing group IVE (ASX:IGL) to a Buy, with a new $1.38 target, implying 44% upside in a year from Friday’s close of $0.96.
  • Elders (ASX:ELD), BidEnergy (ASX:BID) and Fleetwood (ASX:FWD) are all showing bullish charting signals according to Trading Central.

Market Update

Julia Lee
March 2, 2017

How to create a watchscreen

Bell Direct
March 1, 2017

How to set trading alerts

Bell Direct
March 1, 2017

How to transfer your shares to Bell Direct

Bell Direct
February 27, 2017

How to get a stock quote

Bell Direct
February 27, 2017

February newsletter Julia’s insights

Julia Lee
February 24, 2017

CEO interview – Cobalt Blue

Bell Direct
February 21, 2017

Your Money Your Call

Julia Lee
February 14, 2017

Your Money Your Call

Julia Lee
February 7, 2017

January review

Julia Lee
January 27, 2017